N-Acetyl-β-D-Glucosaminidase Kit (MPT Method)

Primary DI

06936595751857

Basic UDI-DI Code

B-06936595751857

Reference

MJ016Y

Device Types

None provided

Regulation

Eu Ivdd

Classification

Eu Ivd General

Status

On The Market

Manufacturer

MedicalSystem Biotechnology Co., Ltd.

For the quantitative in vitro determination of N-Acetyl-β-D-Glucosaminidase activity in urine or serum. N-Acetyl-β-D-Glucosaminidase(MPT Method) is a lysosomal enzyme involved in the breakdown metabolism of glycoproteins. It's reported that increased NAG levels in urine are an early indication of renal disease and can be regarded as a valuable renal monitoring marker in disorders such as nephritic syndrome, glomerulonephritis, drug abuse associated nephrotoxicity, diabeteses-associated nephropathy, hypertension and urinary tract infections[1,2] .

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).